Details of major therapy changes as a result of multidisciplinary team meetings for 2,213 cases | % |
---|---|
Change in steroid treatment | 16.5 |
Change in disease-modifying therapy | 18.8 |
Cessation of disease-modifying therapy | 3.8 |
Start a biologic agent | 1.8 |
Continue a biologic agent | 0.7 |
Stop a biologic agent | 0.1 |
Note: Although a variety of biologic agents were used, the most commonly prescribed within this cohort was rituximab.